Celldex Therapeutics

CLDX

Börsenwert 2,34 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	KE 1 KLP Enterprises Branford, Connecticut	3,1 Mio. $	–	–	–
2	MG 2 Meditor Group Hamilton, Bermuda	2,85 Mio. $	–	–	–
3	3 Vanguard Group Malvern, Pennsylvania	2,73 Mio. $	+196.822 $	+28.113	+7 %
4	4 Renaissance Technologies New York	2,41 Mio. $	+524.109 $	+74.861	+27 %
5	5 BlackRock New York	1,72 Mio. $	+104.190 $	+14.882	+6 %
6	6 Dimensional Fund Advisors Austin, Texas	1,66 Mio. $	-279.085 $	-39.863	-14 %
7	7 TSP Capital Management Group Summit, New Jersey	1,55 Mio. $	-619.926 $	-88.547	Geschlossen
8	8 Deutsche Bank Frankfurt Am Main Ge, Germany	893.000 $	-298.870 $	-42.689	-24 %
9	9 Millennium Management New York	824.000 $	-163.686 $	-23.380	-16 %
10	10 Two Sigma Investments New York	774.000 $	+169.714 $	+24.241	+27 %
11	11 GSA Capital Partners London, United Kingdom	573.000 $	+294.375 $	+42.047	+99 %
12	12 Acadian Asset Management Boston, Massachusetts	490.000 $	-33.507 $	-4.786	-6 %
13	13 Geode Capital Management Boston, Massachusetts	463.000 $	-3.108 $	-444	-0,6 %
14	14 Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada	347.000 $	-60.735 $	-8.675	-14 %
15	15 Northern Trust Chicago, Illinois	309.000 $	-167.501 $	-23.925	-34 %
16	16 Two Sigma Advisers New York	288.000 $	+158.589 $	+22.652	+113 %
17	17 Goldman Sachs New York	238.000 $	-688.831 $	-98.389	-74 %
18	18 State of New Jersey Common Pension Fund D Trenton, New Jersey	214.000 $	–	–	–
19	19 QS Investors New York	174.000 $	–	–	–
20	20 D.E. Shaw & Co New York	138.000 $	-8.114 $	-1.159	-5 %
21	21 Element Capital Management New York	116.000 $	-144.902 $	-20.697	-55 %
22	22 Squarepoint New York	115.000 $	+51.955 $	+7.421	+77 %
23	23 BlueCrest Capital Management St Helier, Jersey	96.000 $	+9.276 $	+1.325	+10 %
24	TI 24 Telemetry Investments New York	84.000 $	-30.854 $	-4.407	-26 %
25	25 California Public Employees Retirement System Sacramento, California	81.000 $	–	–	–

Celldex Therapeutics CLDX Börsenwert 2,34 Mrd. $

Celldex Therapeutics

CLDX

Börsenwert 2,34 Mrd. $